Cargando…
Cetuximab in small bowel adenocarcinoma: a new friend?
Autores principales: | Santini, D, Fratto, M E, Spoto, C, Russo, A, Galluzzo, S, Zoccoli, A, Vincenzi, B, Tonini, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967067/ https://www.ncbi.nlm.nih.gov/pubmed/20842127 http://dx.doi.org/10.1038/sj.bjc.6605898 |
Ejemplares similares
-
Reply: Cetuximab in small bowel adenocarcinoma: a new friend?
por: Overman, M J, et al.
Publicado: (2010) -
First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
por: Tonini, Giuseppe, et al.
Publicado: (2009) -
Response to: Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations
por: Citarella, Fabrizio, et al.
Publicado: (2021) -
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
por: Vincenzi, Bruno, et al.
Publicado: (2012) -
Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
por: Russano, Marco, et al.
Publicado: (2020)